To scroll text in this page

Global Navigation
Global Navigation end

About Astellas Title Image

Start of the main text

News Release 2009

About RSS

Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications(pdf88 KB)

December 18, 2009

Printer-friendly version

  1. Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications(pdf88 KB)
Prev Back to the list Next
Main Text end
Local Navigation
Local Navigation end
Related Links